Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease

NCT05453539 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped A temperature excursion occurred at the drug supplier's storage facility, which led to the loss of a significant portion of the IMP stock. Consequently, there is not enough IMP available to support continued recruitment

Conditions

Interventions

Sponsor

Alzeca Biosciences, Inc.

Collaborators